Luma Foad Manher Al-Ethafa
Environmental Health Department., College of Environmental Science, Al-Qasim Green University, Iraq
*Corresponding author: dr.lumafoad@environ.uoqasim.edu.iq
Received: April 18, 2021 / Revised: May 8 , 2021/ Accepted: June 6, 2020
Abstract
The parasite Trichomonas vaginalis is one of the primary parasites that cause vaginitis and causes Trichomoniasis and is considered a sexually transmitted disease, and it is widespread all over the world. This parasite is an anaerobic flagellar parasite that affects the urinary genital tract in humans and the symptoms associated with it vary between the sexes, and severe infection may cause infertility or delayed childbearing for both sexes. According to WHO reports, there are about 170 million annual cases of this parasite around the world. Due to the risks posed by venereal diseases to society and the lack of studies on such. Diseases This study was conducted to increase knowledge and methods of prevention and treatment of this parasite.
Keywords Trichomonas vaginals, pathogenicity and methods of prevention
How to cite this article:
Al-Ethafa, L.F.M., (2021). Trichomonas vaginals: a review on pathogenicity, diagnosis and treatment. Science Archives, Vol. 2 (2), 75-79 http://dx.doi.org/10.47587/SA.2021.2202
Copyright
This is an open-access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
AL-Naely, AJ, Qasim, MT, & Al-Hamadawi, HA (2021). Transfusion of blood components in the Newborn Service of the Hospital. Annals of the Romanian Society for Cell Biology , 952–958.
Arroyo, R., Engbring, J., & Alderete, J. F. (1992). Molecular basis of host epithelial cell recognition by Trichomonas vaginalis. Molecular microbiology, 6(7), 853-862.doi:10.1111/j.1365-2958.1992.tb01536.x.
Ash, L. R., & Orihel, T. C. (1990).,Atlas of human parasitology (pp. 103-111). Chicago: ASCP Press.
Caini, Saverio; Gandini, Sara; Dudas, Maria; Bremer, Viviane; Severi, Ettore; Gherasim, Alin (2014). “Sexually transmitted infections and prostate cancer risk: A systematic review and meta-analysis”. Cancer Epidemiology. 38 (4):329-338.doi:10.1016/j.canep.2014.06.002. ISSN 1877-7821.
Carlton, J. M., Hirt, R. P., Silva, J. C., Delcher, A. L., Schatz, M., Zhao, Q., … & Johnson, P. J. (2007). Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science, 315(5809), 207-212.doi:10.1126/science.1132894.
Cudmore, S. L., Delgaty, K. L., Hayward-McClelland, S. F., Petrin, D. P., & Garber, G. E. (2004). Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clinical microbiology reviews, 17(4), 783-793.doi:10.1128/CMR.17.4.783-793.2004. PMC 523556.
Donné, A. (1836). Animacules observes dans les matieres purulentes et le produit des secretions des organes genitaux de l’homme et de la femme. CR Acad Sci , 3 , 385–386.
Garber, G. E. (2005). The laboratory diagnosis of Trichomonas vaginalis. Canadian Journal of Infectious Diseases and Medical Microbiology, 16(1), 35-38. doi:10.1155/2005/373920. PMC 2095007.
Gowhari Shabgah, A. G., Qasim, M. T., Mostafavi, S. M., Zekiy, A. O., Ezzatifar, F., Ahmadi, M., … & Navashenaq, J. G. (2021). CXC chemokine ligand 16: a Swiss army knife chemokine in cancer. Expert
Harp, DF, & Chowdhury, I. (2011). Trichomoniasis: evaluation to execution. European Journal of Obstetrics & Gynecology and Reproductive Biology , 157 (1), 3-9. doi:10.1016/j.ejogrb.2011.02.024. PMC 4888369.
Hook III, E. W. (1999). Trichomonas vaginalis-no longer a minor STD. Sexually transmitted diseases, 26(7), 388-389. doi:10.1097/00007435-199908000-00004.
Huppert, J. S., Mortensen, J. E., Reed, J. L., Kahn, J. A., Rich, K. D., Miller, W. C., & Hobbs, M. M. (2007). Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clinical Infectious Diseases, 45(2), 194-198. doi:10.1086/518851.
Hussein, E. M., & Atwa, M. M. (2008). Infectivity of Trichomonas vaginalis pseudocysts inoculated intra-vaginally in mice. Journal of the Egyptian Society of Parasitology, 38(3), 749-762.
Johnston, V. J., & Mabey, D. C. (2008). Global epidemiology and control of Trichomonas vaginalis. Current opinion in infectious diseases, 21(1), 56-64. doi:10.1097/QCO.0b013e3282f3d999. PMID 18192787.
Kengne, P., Veas, F., Vidal, N., Rey, J. L., & CUNY, G. (1994). Specific polymerase chain reaction diagnosis. Cellular and molecular biology, 40(6), 819-831.
Mendoza-López, M. R., Becerril-Garcia, C., Fattel-Facenda, L. V., Avila-Gonzalez, L., Ruíz-Tachiquín, M. E., Ortega-Lopez, J., & Arroyo, R. (2000). CP30, a Cysteine proteinase involved inTrichomonas vaginalis cytoadherence. Infection and immunity, 68(9), 4907-4912. doi:10.1128/IAI.68.9.4907-4912.2000.
Mielczarek, E., & Blaszkowska, J. (2016). Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure. Infection, 44(4), 447-458. doi:10.1007/s15010-015-0860-0.
Mohammed, Z. I., & Qasim, M. T. (2021). Correlation of AMH and LH Levels in PCOS Patients with Pregnancy Rate. Annals of the Romanian Society for Cell Biology, 945-951.
Mousa, H. M., & Qasim, M. T. (2015). Microbial Infection and IL-6 Urine Levels for Pregnant women in Thi-Qar Province. World J. Pharma. Res, 4(05), 358-365.
Nanda, N., Michel, R. G., Kurdgelashvili, G., & Wendel, K. A. (2006). Trichomoniasis and its treatment. Expert review of anti-infective therapy, 4(1), 125-135. doi:10.1586/14787210.4.1.125.
Ohlemeyer, C. L., Hornberger, L. L., Lynch, D. A., & Swierkosz, E. M. (1998). Diagnosis of Trichomonas vaginalis in adolescent females: InPouch TV® culture versus wet-mount microscopy. Journal of adolescent health, 22(3), 205-208.doi:10.1016/S1054-139X(97)00214-0.
Petrin, D., Delgaty, K., Bhatt, R., & Garber, G. (1998). Clinical and microbiological aspects ofTrichomonas vaginalis. Clinical microbiology reviews, 11(2), 300-317. doi:10.1128/CMR.11.2.300.
Powers, C. N. (1998). Diagnosis of infectious diseases: a cytopathologist’s perspective. Clinical microbiology reviews, 11(2), 341-365. doi:10.1128/CMR.11.2.341.
Qasim, M. T., & Al-Mayali, H. K. (2019). Investigate the relation between Baicalin effect and Gene expression of LH, FSH, Testosterone in male rats treated with Gemcitabine drug. Research Journal of Pharmacy and Technology, 12(9), 4135-4141.
Qasim, MT, & Al-Mayali, HK (2019, July). The immunological and protective role of Baicalin in male rats treated with chemotherapy (Gemcitabine). In Journal of Physics: Conference Series (Vol. 1234, No. 1, p. 012065). IOP Publishing.
Ryan, K. J., & Ray, C. G. John C., (2004). Medical microbiology. McGraw Hill, 4, 370. ISBN 978-0-8385-8529-0
Schirm, J., Bos, P. A., Roozeboom-Roelfsema, I. K., Luijt, D. S., & Möller, L. V. (2007). Trichomonas vaginalis detection using real-time TaqMan PCR. Journal of microbiological methods, 68(2), 243-247.
Schwebke, J. R. Burgess D(2004). Trichomoniasis. Clin. Microbiol. Rev, 17(4), 794-803.
Sood, S., Mohanty, S., Kapil, A., Tolosa, J., & Mittal, S. (2007). InPouch TV (TM) culture for detection of Trichomonas vaginalis. Indian J Med Res , 125 , 567.
Soper, D. (2004). Trichomoniasis: under control or undercontrolled?. American journal of obstetrics and gynecology, 190(1), 281-290. doi:10.1016/j.ajog.2003.08.023.
Swygard, H., Sena, A. C., Hobbs, M. M., & Cohen, M. S. (2004). Trichomoniasis: clinical manifestations, diagnosis and management. Sexually transmitted infections, 80(2), 91-95. doi:10.1136/sti.2003.005124.
Tahmasebi, S., Qasim, M. T., Krivenkova, M. V., Zekiy, A. O., Thangavelu, L., Aravindhan, S., … & Roshangar, L. (2021). The effects of oxygen–ozone therapy on regulatory T‐cell responses in multiple sclerosis patients. Cell biology international.
Upcroft, P., & Upcroft, J. A. (2001). Drug targets and mechanisms of resistance in the anaerobic protozoa. Clinical microbiology reviews, 14(1), 150-164. doi:10.1128/CMR.14.1.150-164.2001.
Verges, J. (1979). Les prostatites a trichomonas formes rondes (TFR). [Prostatitis due to the circular form of trichomonas]. Journal d’Urologie et de Nephrologie (in French). 85 (6): 357–361.
License Article Metadata
This work is licensed under a Creative Commons Attribution 4.0 International License.
